Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04764604Not ApplicableCompleted

Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment

Role: collaborator

NCT02864420Not ApplicableCompleted

Hospitalization at Home: The Acute Care Home Hospital Program for Adults

Role: collaborator

NCT02539628Phase 4Completed

Adductor Canal Block With Continuous Infusion Versus Intermittent Boluses and Morphine Consumption

Role: collaborator

NCT01792778Not ApplicableCompleted

RIGHT IV Pilot Study

Role: lead

NCT01997099Completed

A Workflow and Satisfaction Study Evaluating the Implementation of a New "Smart" Ambulatory Infusion System

Role: lead

NCT02523872Unknown

Description of Fluid Balance in Patients With Acute Respiratory Failure

Role: lead

NCT02136446Not ApplicableUnknown

Prospective Post-market Evaluation of an Echogenic Catheter

Role: lead

NCT02119351Not ApplicableCompleted

A Study Evaluating the Clinical Performance of the ViaValve™ Safety IV Catheter

Role: lead

NCT01935284Completed

Evaluation of Blood Gas Syringes

Role: lead

All 9 trials loaded